Renaissance Capital logo

EVH News

US IPO Weekly Recap: DAVIDsTEA boils over, up 42% in a week with four IPOs

Four IPOs raised $613 million in the past week, 11% more than expected thanks to two high-growth consumer and tech IPOs. IPO investors have been discerning: two IPOs priced above the range, one yield play came in at its midpoint and one medical device company went public at the low end of the range. We...read more

Evolent Health prices upsized IPO above the range at $17

EVH

Evolent Health, which provides advisory services and an IT platform to help health systems adopt an outcomes-based business model, raised $195.5 million in an upsized IPO by offering 11.5 million shares at $17, above the range of $14 to $16. The company originally planned to offer 10 million shares. Evolent Health plans to list on the NYSE under the symbol EVH. Evolent Health...read more

Week ahead: 4 IPOs planned for the week of June 1

EVH

The IPO market will kick off June with four initial public offerings set to raise $550 million. The four on the calendar are each in different industries, including tech, consumer, energy and health care. This marks the third week without a biotech IPO - the longest stretch since the beginning of the year. ...read more

High-growth health-tech: Evolent Health sets terms for $150 million IPO

EVH

Evolent Health, which offers health care providers a software platform for managing value-based care, announced terms for its IPO on Tuesday. The Arlington, VA-based company plans to raise $150 million by offering 10 million shares at a price range of $14 to $16. At the midpoint of the proposed range, Evolent Health would command a fully diluted market value of $891 million. ...read more